SCHEMBL25504875

SCHEMBL25504875

CC[C@H]1OC(OC(C)=O)[C@@H](OC(=O)c2ccccc2)[C@@H]1C

nearest known ligand 0.43

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LGALS9 O00182 1/20 0.43
LGALS1 P09382 1/20 0.43
LGALS3 P17931 1/20 0.43
LGALS7; LGALS7B P47929 1/20 0.43
PTPN1 P18031 2/20 0.40
LMNA P02545 2/20 0.39
TSHR P16473 3/20 0.39
ABCB1 P08183 8/20 0.38
NT5E P21589 1/20 0.37
BCHE P06276 2/20 0.37
KMT2A Q03164 1/20 0.36
SLC43A1 O75387 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25504933 1.00 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL29323260 1.00 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL25524899 1.00 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL10024720 1.00 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL15837375 1.00 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL17322467 1.00 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL16769132 1.00 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL17211042 1.00 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL25504930 1.00 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1
SCHEMBL25504609 1.00 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159922-A1 MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2023-05-25 US disclosed